
Aggressive glucose control in patients with type 2 diabetes, while improving surrogate markers of kidney disease, has not been proven to reduce the risk of adverse clinically meaningful renal outcomes, according to a systematic review and meta-analysis of 7 clinical trials. Key Point: Tight glycemic targets in patients diagnosed with…
Read more »
Intensive glucose control does not prevent renal failure and carries risk of severe hypoglycemia
Aggressive glucose control in patients with type 2 diabetes, while improving surrogate markers of kidney disease, has not been proven to reduce the risk of adverse clinically meaningful renal outcomes, according to a systematic review and meta-analysis of 7 clinical trials. Key Point: Tight glycemic targets in patients diagnosed with…
Read more »